FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Voravit Ratanatharathorn

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Lawrence G Lum; Alice Mitchell; Cassara Pray; Muneer H Abidi; Zaid Al-Kadhimi; Lois Jeanne Ayash; Abhinav Deol; Melissa Dufresne; Qin Liu; Dana L Schalk; Patricia A Steele; Archana Thakur; Elyse N Tomaszewski; Joseph Primo Uberti; Hiroshi Yano; Voravit Ratanatharathorn
CD20-Targeted T Cells after Stem Cell Transplantation for High Risk and Refractory Non-Hodgkin's Lymphoma.
Muneer H Abidi; Judith Abrams; Rishi Agarwal; Zaid Al-Kadhimi; Lois Jeanne Ayash; Simon Cronin; Abhinav Deol; Lawrence George Lum; Voravit Ratanatharathorn; Nishant Tageja; Marie Ventimiglia; Jeffrey A Zonder; Joseph Primo Uberti
A phase I dose-escalation trial of high-dose melphalan with palifermin for cytoprotection followed by autologous stem cell transplantation for patients with multiple myeloma with normal renal function.
Vanderson Rocha; Annalisa Ruggeri; Stephen Spellman; Jon J van Rood; Mei-Jie Zhang; Etienne Baudoux; Lee Ann Baxter-Lowe; Paola Bergamaschi; Colleen Brady; Robert Chow; Mary Eapen; Brian Freed; Eliane Gluckman; Mary M Horowitz; Gesine Koegler; Joanne Kurtzberg; Jérôme Larghero; Lucilla Lecchi; Arnon Nagler; Cristina Navarrette; Fabienne Pouthier; Vinod Prasad; Thomas Price; Duncan Purtill; Voravit Ratanatharathorn
Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Voravit Ratanatharathorn (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Lawrence G Lum; Alice Mitchell; Cassara Pray; Muneer H Abidi; Zaid Al-Kadhimi; Lois Jeanne Ayash; Abhinav Deol; Melissa Dufresne; Qin Liu; Dana L Schalk; Patricia A Steele; Archana Thakur; Elyse N Tomaszewski; Joseph Primo Uberti; Hiroshi Yano; Voravit Ratanatharathorn
CD20-Targeted T Cells after Stem Cell Transplantation for High Risk and Refractory Non-Hodgkin's Lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(6):925-33.
2013: Muneer H Abidi; Judith Abrams; Rishi Agarwal; Zaid Al-Kadhimi; Lois Jeanne Ayash; Simon Cronin; Abhinav Deol; Lawrence George Lum; Voravit Ratanatharathorn; Nishant Tageja; Marie Ventimiglia; Jeffrey A Zonder; Joseph Primo Uberti
A phase I dose-escalation trial of high-dose melphalan with palifermin for cytoprotection followed by autologous stem cell transplantation for patients with multiple myeloma with normal renal function.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(1):56-61.
2012: Vanderson Rocha; Annalisa Ruggeri; Stephen Spellman; Jon J van Rood; Mei-Jie Zhang; Etienne Baudoux; Lee Ann Baxter-Lowe; Paola Bergamaschi; Colleen Brady; Robert Chow; Mary Eapen; Brian Freed; Eliane Gluckman; Mary M Horowitz; Gesine Koegler; Joanne Kurtzberg; Jérôme Larghero; Lucilla Lecchi; Arnon Nagler; Cristina Navarrette; Fabienne Pouthier; Vinod Prasad; Thomas Price; Duncan Purtill; Voravit Ratanatharathorn
Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(12):1890-6.
2012: Zaid Al-Kadhimi; Lois Jeanne Ayash; Wei Chen; Abhinav Deol; Stephen Forman; Zartash Gul; Lawrence George Lum; Alice Mitchell; Voravit Ratanatharathorn; Roberto Rodriguez; Daryn Smith; Muneer H Abidi; Joseph Primo Uberti
Anti-thymocyte globulin (thymoglobulin), tacrolimus, and sirolimus as acute graft-versus-host disease prophylaxis for unrelated hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(11):1734-44.
2012: Muneer H Abidi; Judith Abrams; Zaid Al-Kadhimi; Lois Jeanne Ayash; Simon Cronin; Lawrence George Lum; Voravit Ratanatharathorn; Nishant Tageja; Marie Ventimiglia; Joseph Primo Uberti
Aprepitant for prevention of nausea and vomiting secondary to high-dose cyclophosphamide administered to patients undergoing autologous peripheral blood stem cells mobilization: a phase II trial.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2012;20(10):2363-9.
2012: Muneer H Abidi; Judith Abrams; Rishi Agarwal; Zaid Al-Kadhimi; Lois Jeanne Ayash; Simon Cronin; Abhinav Deol; Lawrence George Lum; Voravit Ratanatharathorn; Marie Ventimiglia; Jeffrey A Zonder; Joseph Primo Uberti
Melphalan 180 mg/m2 can be safely administered as conditioning regimen before an autologous stem cell transplantation (ASCT) in multiple myeloma patients with creatinine clearance 60 mL/min/1.73 m2 or lower with use of palifermin for cytoprotection: results of a phase I trial.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(9):1455-61.
2012: Muneer H Abidi; Judith Abrams; Zaid Al-Kadhimi; Lois Jeanne Ayash; Abhinav Deol; Zartash Gul; Lawrence George Lum; Stephanie Mellon-Reppen; Voravit Ratanatharathorn; Marie Ventimiglia; Jeffrey A Zonder; Joseph Primo Uberti
Phase I trial of bortezomib during maintenance phase after high dose melphalan and autologous stem cell transplantation in patients with multiple myeloma.
Journal of chemotherapy (Florence, Italy) 2012;24(3):167-72.
2012: Archana Thakur; Carly Sorenson; Voravit Ratanatharathorn; Oxana Norkina; Dana Schalk; Lawrence George Lum
Activated T cells from umbilical cord blood armed with anti-CD3 × anti-CD20 bispecific antibody mediate specific cytotoxicity against CD20+ targets with minimal allogeneic reactivity: a strategy for providing antitumor effects after cord blood transplants.
Transfusion 2012;52(1):63-75.
2011: M Norkin; Voravit Ratanatharathorn; Muneer H Abidi; Zaid Al-Kadhimi; Lois Jeanne Ayash; Lawrence George Lum; Joseph Primo Uberti
Large pericardial effusion as a complication in adults undergoing SCT.
Bone marrow transplantation 2011;46(10):1353-6.
2011: Joseph Primo Uberti; M-A Agovi; S Tarima; M Haagenson; S Gandham; C Anasetti; K S Baker; B J Bolwell; M Bornhauser; K W Chan; E Copelan; S M Davies; J Finke; gregory alan hale; C Kollman; P L McCarthy; Voravit Ratanatharathorn; O Ringdén; D J Weisdorf; J D Rizzo
Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia.
Bone marrow transplantation 2011;46(1):34-43.
2010: S Mellon-Reppen; Voravit Ratanatharathorn; S Cronin; Joseph Primo Uberti
Repeated course of rituximab for treatment of nephrotic syndrome in patients with chronic GVHD.
Bone marrow transplantation 2010;45(12):1758-9.
2010: Ehab Atallah; Judith Abrams; Lois Jeanne Ayash; Gail Bentley; Muneer H Abidi; Voravit Ratanatharathorn; Joseph Primo Uberti
Long term follow-up of allogeneic stem cell transplantation in patients with myelodysplastic syndromes using busulfan, cytosine arabinoside, and cyclophosphamide.
American journal of hematology 2010;85(8):579-83.
2010: Amin M Alousi; Joseph Primo Uberti; Voravit Ratanatharathorn
The role of B cell depleting therapy in graft versus host disease after allogeneic hematopoietic cell transplant.
Leukemia & lymphoma 2010;51(3):376-89.
2009: Voravit Ratanatharathorn; Steven Pavletic; Joseph Primo Uberti
Clinical applications of rituximab in allogeneic stem cell transplantation: anti-tumor and immunomodulatory effects.
Cancer treatment reviews 2009;35(8):653-61.
2009: Douglas Adkins; Voravit Ratanatharathorn; Harry Yang; Barbara A White
Safety profile and clinical outcomes in a phase I, placebo-controlled study of siplizumab in acute graft-versus-host disease.
Transplantation 2009;88(2):198-202.
2009: Voravit Ratanatharathorn; Brent Logan; Dan Wang; Mary Horowitz; Joseph Primo Uberti; Olle Ringden; Robert Peter Gale; Hanna Khoury; Mukta Arora; Stephen Spellman; Corey Cutler; Joseph Antin; Martin Bornhaüser; Gregory Hale; Leo Verdonck; Mitchell S Cairo; Vikas Gupta; Steven Pavletic
Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation.
British journal of haematology 2009;145(6):816-24.
2009: Rami B Ibrahim; Muneer H Abidi; Simon M Cronin; Lawrence George Lum; Zaid Al-Kadhimi; Voravit Ratanatharathorn; Joseph Primo Uberti
Nonabsorbable corticosteroids use in the treatment of gastrointestinal graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(4):395-405.
2009: Dimitrios P Kontoyiannis; Voravit Ratanatharathorn; J-A Young; J Raymond; M Laverdière; D W Denning; Thomas Patterson; D Facklam; L Kovanda; L Arnold; W Lau; D Buell; Kieren Marr
Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis.
Transplant infectious disease : an official journal of the Transplantation Society 2009;11(1):89-93.
2008: Frank Wang; Luis Garza; Soyun Cho; Reza Kafi; Craig Hammerberg; Taihao Quan; Ted Hamilton; MD Mayes; Voravit Ratanatharathorn; John J Voorhees; Gary J Fisher; Sewon Kang
Effect of increased pigmentation on the antifibrotic response of human skin to UV-A1 phototherapy.
Archives of dermatology 2008;144(7):851-8.
2007: Lois Jeanne Ayash; Voravit Ratanatharathorn; Thomas Braun; Samuel Michael Silver; Christopher M Reynolds; Joseph Primo Uberti
Unrelated donor bone marrow transplantation using a chemotherapy-only preparative regimen for adults with high-risk acute myelogenous leukemia.
American journal of hematology 2007;82(1):6-14.
2006: David W Denning; Kieren Marr; Wendi M Lau; David P Facklam; Voravit Ratanatharathorn; Cornelia Becker; Andrew J Ullmann; Nita L Seibel; Patricia M Flynn; Jo-Anne H van Burik; Donald N Buell; Thomas Patterson
Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis.
The Journal of infection 2006;53(5):337-49.
2006: Pavan Reddy; Kent J Johnson; Joseph Primo Uberti; Christopher Reynolds; Samuel Michael Silver; Lois Jeanne Ayash; Thomas M Braun; Voravit Ratanatharathorn
Nephrotic syndrome associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Bone marrow transplantation 2006;38(5):351-7.
2006: Flora Hoodin; Joseph Primo Uberti; T J Lynch; P Steele; Voravit Ratanatharathorn
Do negative or positive emotions differentially impact mortality after adult stem cell transplant?
Bone marrow transplantation 2006;38(4):255-64.
2006: Drew J Winston; Lindsey R Baden; Don A Gabriel; Christos Emmanouilides; Leslie M Shaw; W Robert Lange; Voravit Ratanatharathorn
Pharmacokinetics of ganciclovir after oral valganciclovir versus intravenous ganciclovir in allogeneic stem cell transplant patients with graft-versus-host disease of the gastrointestinal tract.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(6):635-40.
2005: Joseph Primo Uberti; Lois Jeanne Ayash; Voravit Ratanatharathorn; Samuel Michael Silver; Christopher Reynolds; Michael Becker; Pavan Reddy; Kenneth R Cooke; Gregory Yanik; Joel Whitfield; Dawn Jones; Raymond J Hutchinson; Thomas Braun; James L M Ferrara; John E Levine
Pilot trial on the use of etanercept and methylprednisolone as primary treatment for acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(9):680-7.
2004: Cesar O Freytes; Voravit Ratanatharathorn; Charles Taylor; Camille Abboud; Nancy Chesser; Alejandro Restrepo; Jorge Arango; Daniel Odenheimer
Phase I/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(24):8318-24.
2004: Jo-Anne H van Burik; Voravit Ratanatharathorn; Daniel E Stepan; Carole B Miller; Jeffrey H Lipton; David H Vesole; Nancy Bunin; Donna A Wall; John W Hiemenz; Yoichi Satoi; Jeanette M Lee; THOMAS WALSH
Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(10):1407-16.
2004: Joseph Primo Uberti; Lois Jeanne Ayash; Thomas Braun; Christopher Reynolds; Samuel Michael Silver; Voravit Ratanatharathorn
Tacrolimus as monotherapy or combined with minidose methotrexate for graft-versus-host disease prophylaxis after allogeneic peripheral blood stem cell transplantation: long-term outcomes.
Bone marrow transplantation 2004;34(5):425-31.
2004: Flora Hoodin; Karen R Kalbfleisch; James Thornton; Voravit Ratanatharathorn
Psychosocial influences on 305 adults' survival after bone marrow transplantation; depression, smoking, and behavioral self-regulation.
Journal of psychosomatic research 2004;57(2):145-54.
2004: Laura A Dawson; Naoyuki G Saito; Voravit Ratanatharathorn; Joseph Primo Uberti; Paul T Adams; Lois Jeanne Ayash; Christopher M Reynolds; Samuel Michael Silver; Matthew Schipper; Allen S Lichter; Avraham Eisbruch
Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
International journal of radiation oncology, biology, physics 2004;59(1):208-18.
2004: Pavan Reddy; Robertson D Davenport; Voravit Ratanatharathorn; Christopher Reynolds; Samuel Michael Silver; Lois Jeanne Ayash; James L M Ferrara; Joseph Primo Uberti
West Nile virus encephalitis causing fatal CNS toxicity after hematopoietic stem cell transplantation.
Bone marrow transplantation 2004;33(1):109-12.
2003: Voravit Ratanatharathorn; Lois Jeanne Ayash; Christopher Reynolds; Samuel Michael Silver; Pavan Reddy; Michael Becker; James L M Ferrara; Joseph Primo Uberti
Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(8):505-11.
2003: John E Levine; Joseph Primo Uberti; Lois Jeanne Ayash; Christopher Reynolds; James L M Ferrara; Samuel Michael Silver; Thomas Braun; Gregory Yanik; Raymond J Hutchinson; Voravit Ratanatharathorn
Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays acute graft-versus-host disease but does not improve outcome for advanced hematologic malignancy.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(3):189-97.
2001: Lois Jeanne Ayash; M Clarke; P Adams; James L M Ferrara; Voravit Ratanatharathorn; C Reynolds; Blake J Roessler; Samuel Michael Silver; Myla S Strawderman; Joseph Primo Uberti; Max S Wicha
Clinical protocol. Purging of autologous stem cell sources with bcl-x(s) adenovirus for women undergoing high-dose chemotherapy for stage IV breast carcinoma.
Human gene therapy 2001;12(16):2023-5.
2001: P Jacobson; J Ng; Voravit Ratanatharathorn; Joseph Primo Uberti; Richard C Brundage
Factors affecting the pharmacokinetics of tacrolimus (FK506) in hematopoietic cell transplant (HCT) patients.
Bone marrow transplantation 2001;28(8):753-8.
2001: Craig Kollman; C W Howe; Claudio Anasetti; Joseph H Antin; Stella M Davies; Alexandra H Filipovich; Janet Hegland; Naynesh Kamani; Nancy A Kernan; Roberta King; Voravit Ratanatharathorn; Daniel Weisdorf; Dennis L Confer
Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age.
Blood 2001;98(7):2043-51.
2001: Voravit Ratanatharathorn; Lois Jeanne Ayash; Hillard M Lazarus; J Fu; Joseph Primo Uberti
Chronic graft-versus-host disease: clinical manifestation and therapy.
Bone marrow transplantation 2001;28(2):121-9.
2001: Lois Jeanne Ayash; M Clarke; Samuel Michael Silver; Thomas Braun; Joseph Primo Uberti; Voravit Ratanatharathorn; Christopher Reynolds; James L M Ferrara; E R Broun; Paul T Adams
Double dose-intensive chemotherapy with autologous stem cell support for relapsed and refractory testicular cancer: the University of Michigan experience and literature review.
Bone marrow transplantation 2001;27(9):939-47.
2001: Christopher Reynolds; Voravit Ratanatharathorn; P Adams; Thomas Braun; Samuel Michael Silver; Lois Jeanne Ayash; E Carson; Avraham Eisbruch; Laura A Dawson; Kevin T McDonagh; James L M Ferrara; Joseph Primo Uberti
Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma.
Bone marrow transplantation 2001;27(8):801-7.
2000: S Cronin; Joseph Primo Uberti; Lois Jeanne Ayash; C Raith; Voravit Ratanatharathorn
Use of amifostine as a chemoprotectant during high-dose chemotherapy in autologous peripheral blood stem cell transplantation.
Bone marrow transplantation 2000;26(11):1247-9.
2000: Richard A Nash; Joseph H Antin; Chatchada Karanes; Joseph W Fay; Belinda R Avalos; A M Yeager; Donna Przepiorka; S Davies; F B Petersen; P Bartels; Donald N Buell; William E Fitzsimmons; Claudio Anasetti; Rainer Storb; Voravit Ratanatharathorn
Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors.
Blood 2000;96(6):2062-8.
2000: Voravit Ratanatharathorn; E Carson; Christopher Reynolds; Lois Jeanne Ayash; John E Levine; Gregory Yanik; Samuel Michael Silver; James L M Ferrara; Joseph Primo Uberti
Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease.
Annals of internal medicine 2000;133(4):275-9.
2000: Gregory Yanik; John E Levine; Voravit Ratanatharathorn; R Dunn; James L M Ferrara; Raymond J Hutchinson
Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation.
Bone marrow transplantation 2000;26(2):161-7.
1999: Joseph Primo Uberti; S Cronin; Voravit Ratanatharathorn
Optimum use of tacrolimus in the prophylaxis of graft versus host disease.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 1999;11(5):343-58.
1998: Donna Przepiorka; G L Phillips; Voravit Ratanatharathorn; M Cottler-Fox; L H Sehn; Joseph H Antin; D LeBherz; Michel Awwad; James Hope; J B McClain
A phase II study of BTI-322, a monoclonal anti-CD2 antibody, for treatment of steroid-resistant acute graft-versus-host disease.
Blood 1998;92(11):4066-71.
1998: D Choi; M Perrin; S Hoffmann; Alfred E Chang; Voravit Ratanatharathorn; Joseph Primo Uberti; Kevin T McDonagh; James J Mulé
Dendritic cell-based vaccines in the setting of peripheral blood stem cell transplantation: CD34+ cell-depleted mobilized peripheral blood can serve as a source of potent dendritic cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(11):2709-16.
1998: Voravit Ratanatharathorn; Richard A Nash; Donna Przepiorka; Steven M Devine; Jared L Klein; Daniel Weisdorf; Joseph W Fay; Auayporn Nademanee; Joseph H Antin; Neal Christiansen; R van der Jagt; Roger H Herzig; Mark R Litzow; Steven Neil Wolff; W L Longo; F B Petersen; Chatchada Karanes; Belinda R Avalos; Rainer Storb; Donald N Buell; Rochelle M Maher; William E Fitzsimmons; John R Wingard
Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation.
Blood 1998;92(7):2303-14.
1998: P Jacobson; Joseph Primo Uberti; W Davis; Voravit Ratanatharathorn
Tacrolimus: a new agent for the prevention of graft-versus-host disease in hematopoietic stem cell transplantation.
Bone marrow transplantation 1998;22(3):217-25.
1998: John R Wingard; Richard A Nash; Donna Przepiorka; Jared L Klein; Daniel J Weisdorf; Joseph W Fay; J Zhu; Rochelle M Maher; William E Fitzsimmons; Voravit Ratanatharathorn
Relationship of tacrolimus (FK506) whole blood concentrations and efficacy and safety after HLA-identical sibling bone marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1998;4(3):157-63.
1997: Mary Varterasian; N Janakiraman; Chatchada Karanes; Esteban Abella; Joseph Primo Uberti; J Dragovic; S B Raman; Ayad Al-Katib; Wei Du; Samuel Michael Silver; Paul T Adams; L Sensenbrenner; Voravit Ratanatharathorn
Transplantation in patients with multiple myeloma: a multicenter comparative analysis of peripheral blood stem cell and allogeneic transplant.
American journal of clinical oncology 1997;20(5):462-6.
1997: John R Wingard; Richard A Nash; Voravit Ratanatharathorn; Joseph W Fay; Jared L Klein; Donna Przepiorka; Rochelle M Maher; Steven M Devine; GW Boswell; Ihor Bekersky; William E Fitzsimmons
Lack of interaction between tacrolimus (FK506) and methotrexate in bone marrow transplant recipients.
Bone marrow transplantation 1997;20(1):49-51.
1997: Joseph Primo Uberti; Samuel Michael Silver; Paul T Adams; P Jacobson; Anthony A Scalzo; Voravit Ratanatharathorn
Tacrolimus and methotrexate for the prophylaxis of acute graft-versus-host disease in allogeneic bone marrow transplantation in patients with hematologic malignancies.
Bone marrow transplantation 1997;19(12):1233-8.
1995: Mary Varterasian; Voravit Ratanatharathorn; Joseph Primo Uberti; Chatchada Karanes; Esteban Abella; F Momin; C Kasten-Sportes; Ayad Al-Katib; Lawrence George Lum; Lance K Heilbrun
Clinical course and outcome of patients with Hodgkin's disease who progress after autologous transplantation.
Leukemia & lymphoma 1995;20(1-2):59-65.
1995: T Y Shibuya; F Momin; Esteban Abella; John R Jacobs; Chatchada Karanes; Voravit Ratanatharathorn; L L Sensenbrenner; Lawrence George Lum
Sinus disease in the bone marrow transplant population: incidence, risk factors, and complications.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 1995;113(6):705-11.
1995: N R Jin; Lawrence George Lum; Voravit Ratanatharathorn; L L Sensenbrenner
Anti-CD3-activated splenocytes enhance survival in lethally irradiated mice after transplant of syngeneic hematopoietic stem cells.
Experimental hematology 1995;23(13):1331-6.
1995: Mary Varterasian; Voravit Ratanatharathorn; Chatchada Karanes; Joseph Primo Uberti; F Momin; Esteban Abella; Lawrence George Lum; Lance K Heilbrun; L L Sensenbrenner
Bone marrow transplantation for multiple myeloma: the Wayne State experience.
Bone marrow transplantation 1995;15(2):328-9.
1994: Voravit Ratanatharathorn; Joseph Primo Uberti; Chatchada Karanes; Esteban Abella; Lawrence George Lum; F Momin; G Cummings; L L Sensenbrenner
Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma.
Blood 1994;84(4):1050-5.
1994: Joseph Primo Uberti; Voravit Ratanatharathorn; Chatchada Karanes; L L Sensenbrenner
Allogeneic bone marrow transplantation in patients with myelodysplastic syndromes.
Leukemia & lymphoma 1994;14(5-6):379-85.
1994: Kirk R Schultz; Voravit Ratanatharathorn; Esteban Abella; A B Eisenbrey; Chatchada Karanes; Lawrence George Lum; M M de Planque; Joseph Primo Uberti; Yaddanapudi Ravindranath; L L Sensenbrenner
Graft failure in children receiving HLA-mismatched marrow transplants with busulfan-containing regimens.
Bone marrow transplantation 1994;13(6):817-22.
1994: Voravit Ratanatharathorn; Joseph Primo Uberti; Chatchada Karanes; Lawrence George Lum; Esteban Abella; M E Dan; M Hussein; L L Sensenbrenner
Phase I study of alpha-interferon augmentation of cyclosporine-induced graft versus host disease in recipients of autologous bone marrow transplantation.
Bone marrow transplantation 1994;13(5):625-30.
1994: F G LeVeque; Voravit Ratanatharathorn; M E Dan; B Orville; D N Coleman; S Turner
Oral cytomegalovirus infection in an unrelated bone marrow transplantation with possible mediation by graft-versus-host disease and the use of cyclosporin-A.
Oral surgery, oral medicine, and oral pathology 1994;77(3):248-53.
1994: Lawrence George Lum; I D Joshi; Mitchell R Smith; Voravit Ratanatharathorn; S C Galoforo; Chatchada Karanes; Joseph Primo Uberti; L L Sensenbrenner
Constitutive and mitogen-stimulated cytokine mRNA expression by peripheral blood mononuclear cells from most autologous and allogeneic bone marrow transplant recipients is intact.
Bone marrow transplantation 1994;13(2):187-95.
1993: Lawrence George Lum; I D Joshi; S C Galoforo; Esteban Abella; Chatchada Karanes; Voravit Ratanatharathorn; Kirk R Schultz; Joseph Primo Uberti; L L Sensenbrenner; J A Ledbetter
Coactivation with anti-CD28 monoclonal antibody enhances anti-CD3 monoclonal antibody-induced proliferation and IL-2 synthesis in T cells from autologous bone marrow transplant recipients.
Bone marrow transplantation 1993;12(6):565-71.
1993: Anwar N Mohamed; Jill A Macoska; Anne Kallioniemi; Olli Kallioniemi; Frederic M Waldman; Voravit Ratanatharathorn; Sandra R Wolman
Extrachromosomal gene amplification in acute myeloid leukemia; characterization by metaphase analysis, comparative genomic hybridization, and semi-quantitative PCR.
Genes, chromosomes & cancer 1993;8(3):185-9.
1993: Voravit Ratanatharathorn; Chatchada Karanes; Joseph Primo Uberti; Lawrence George Lum; M M de Planque; Kirk R Schultz; S Cronin; M E Dan; Anwar N Mohamed; M Hussein
Busulfan-based regimens and allogeneic bone marrow transplantation in patients with myelodysplastic syndromes.
Blood 1993;81(8):2194-9.
1992: Voravit Ratanatharathorn; Chatchada Karanes; Lawrence George Lum; Joseph Primo Uberti; M E Dan; M M de Planque; Kirk R Schultz; S Cronin; M C Leisz; Anwar N Mohamed
Allogeneic bone marrow transplantation in high-risk myeloid disorders using busulfan, cytosine arabinoside and cyclophosphamide (BAC).
Bone marrow transplantation 1992;9(1):49-55.
1991: W Negendank; D Weissman; T M Bey; M M de Planque; Chatchada Karanes; Mitchell R Smith; Voravit Ratanatharathorn; Carter R Bishop; Ayad Al-Katib; L L Sensenbrenner
Evidence for clonal disease by magnetic resonance imaging in patients with hypoplastic marrow disorders.
Blood 1991;78(11):2872-9.
1990: M Yamagami; P W McFadden; S M Koethe; Voravit Ratanatharathorn; Lawrence George Lum
Failure of T cell receptor-anti-CD3 monoclonal antibody interaction in T cells from marrow recipients to induce increases in intracellular ionized calcium.
The Journal of clinical investigation 1990;86(4):1347-51.
1987: Ben D Chen; T H Chou; Voravit Ratanatharathorn
Expression of gamma-interferon receptor in murine bone marrow-derived macrophages associated with macrophage differentiation: evidence of gamma-interferon receptors in the regulation of macrophage proliferation.
Journal of cellular physiology 1987;133(2):313-20.
1987: Richard Leavitt; Voravit Ratanatharathorn; Howard Ozer; J E Ultmann; Carol S Portlock; J W Myers; D Kisner; S Norred; R J Spiegel; E M Bonnem
Alfa-2b interferon in the treatment of Hodgkin's disease and non-Hodgkin's lymphoma.
Seminars in oncology 1987;14(2 Suppl 2):18-23.
1987: S Martino; Voravit Ratanatharathorn; Chatchada Karanes; B A Samal; Y H Sohn; S A Rudnick
Reversible arrhythmias observed in patients treated with recombinant alpha 2 interferon.
Journal of cancer research and clinical oncology 1987;113(4):376-8.
1986: S Bhansali; Chatchada Karanes; W Palutke; Lawrence R Crane; R Kiel; Voravit Ratanatharathorn
Successful treatment of disseminated Trichosporon beigelii (cutaneum) infection with associated splenic involvement.
Cancer 1986;58(8):1630-2.
1986: Chatchada Karanes; Voravit Ratanatharathorn; R B Schilcher; J D Young; D Emmer; J A Hoschner; L Leichman; Laurence H Baker
High-dose mitomycin-C with autologous bone marrow transplantation in patients with refractory malignancies. Influence of dose schedule on pharmacokinetics and nonhematopoietic toxicities.
American journal of clinical oncology 1986;9(5):444-8.
1986: Margarida Palutke; Bertram Schnitzer; D Dresner; Pam Tabaczka; Voravit Ratanatharathorn; L Eisenberg; D Tenenbaum
Comparison of morphologic features and mitotic rate to cytometrically determined DNA content of poorly differentiated lymphocytic lymphomas.
Annals of the New York Academy of Sciences 1986;468():178-94.
1984: David Kessel; C Wilberding; Chatchada Karanes; Voravit Ratanatharathorn
Daunorubicin accumulation by human myeloblasts varying in anthracycline resistance.
Cancer letters 1984;24(3):305-9.
1984: R B Schilcher; J D Young; Voravit Ratanatharathorn; Chatchada Karanes; Laurence H Baker
Clinical pharmacokinetics of high-dose mitomycin C.
Cancer chemotherapy and pharmacology 1984;13(3):186-90.
1983: Voravit Ratanatharathorn; M K Samson; Laurence H Baker; R Pollard; G Cummings; R J Fraile
Combination chemotherapy with mitomycin C, adriamycin, and cyclophosphamide (MAC) in stage III and IV ovarian cancer.
American journal of clinical oncology 1983;6(5):565-70.
1983: Voravit Ratanatharathorn; M K Samson; C D Haas; G D Cummings; E J O'Connor; Laurence H Baker
Phase II evaluation of 1-(2-chloroethyl)-3-(2,6-dioxo-(piperidyl)-1 nitrosourea (PCNU)(NSC-95466) in patients with advanced carcinoma of the lung.
American journal of clinical oncology 1983;6(1):99-102.
1982: Voravit Ratanatharathorn; N Gad-el-Mawla; H E Wilson; J D Bonnet; S E Rivkin; R Mass
Phase II evaluation of maytansine in refractory non-Hodgkin's lymphoma: a Southwest Oncology Group study.
Cancer treatment reports 1982;66(7):1687-8.
1982: Voravit Ratanatharathorn; Laurence H Baker; L Balducci; R W Talley; B Hoogstraten
Phase II trial of dianhydrogalactitol in advanced renal cell carcinoma: a Southwest Oncology Group study.
Cancer treatment reports 1982;66(5):1231-2.
1982: Voravit Ratanatharathorn; A Drelichman; M Sexon-Porte; M Al-Sarraf
Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m--anisidine (AMSA) in patients with advanced head and neck cancers.
American journal of clinical oncology 1982;5(1):29-32.
1981: Lawrence R Crane; J A Kish; Voravit Ratanatharathorn; J R Merline; M F Raval
Fatal syncytial virus pneumonia in a laminar airflow room.
JAMA : the journal of the American Medical Association 1981;246(4):366-7.
1980: Margarida Palutke; Pam Tabaczka; R W Weise; A Axelrod; C Palacas; H Margolis; P Khilanani; Voravit Ratanatharathorn; J Piligian; R Pollard; M Husain
T-cell lymphomas of large cell type. A variety of malignant lymphomas: "histiocytic" and mixed lymphocytic-"histiocytic".
Cancer 1980;46(1):87-101.
1979: David Kessel; Voravit Ratanatharathorn; T H Chou
Electrofocusing patterns of fucosyltransferases in plasma of patients with neoplastic disease.
Cancer research 1979;39(9):3377-80.
1978: J K Jain; Voravit Ratanatharathorn; R Golwala; P Khilanani
Practical approach to laparotomy for staging in the management of lymphomas.
Surgery, gynecology & obstetrics 1978;146(6):914-6.
1978: P Khilanani; T H Chou; Voravit Ratanatharathorn; David Kessel
Evaluation of two plasma fucosyltransferases as marker enzymes in non-Hodgkin's lymphoma.
Cancer 1978;41(2):701-5.
1976: M K Samson; Laurence H Baker; R M Izbicki; Voravit Ratanatharathorn
Phase 1-11 study of DTIC and cyclocytidine in disseminated malignant melanoma.
Cancer treatment reports 1976;60(9):1369-71.
1971: P Jayanetra; Voravit Ratanatharathorn
Candida guilliermondii septicemia.
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 1971;54(9):660-6.